Literature DB >> 22371119

Alterations of gene expression of sodium channels in dorsal root ganglion neurons of estrogen receptor knockout (ERKO) mice induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

Haixia Ding1, Qiang Wang, Jingli Liu, Wenyi Qian, Wenjuan Wang, Jun Wang, Rong Gao, Hang Xiao.   

Abstract

Estrogen receptors (ERα and ERβ) mediate the neuroprotection of estrogens against MPTP-induced striatal dopamine (DA) depletion. Pain is an important and distressing symptom in Parkinson's disease (PD). Voltage-gated sodium channels in sensory neurons are involved in the development of neuropathic pain. In this study, MPTP caused changes in nociception and alterations of gene expression of voltage-gated sodium channels in dorsal root ganglion (DRG) neurons in ER knockout (ERKO) mice were investigated. We found that administration of MPTP (11 mg/kg) to WT mice led to an extensive depletion of DA and its two metabolites, αERKO mice were observed to be more susceptible to MPTP toxicity than βERKO or WT mice. In addition, we found that the mRNA levels of TTX-S and TTX-R sodium channel subtypes were differentially affected in MPTP-treated WT animals. The MPTP-induced up-regulation of Nav1.1 and Nav1.9, down-regulation of Nav1.6 in DRG neurons may be through ERβ, up-regulation of Nav1.7 and down-regulation of Nav1.8 are dependent on both ERα and ERβ. Therefore, the MPTP-induced alterations of gene expression of sodium channels in DRG neurons could be an important mechanism to affect excitability and nociceptive thresholds, and the ERs appear to play a role in nociception in PD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22371119     DOI: 10.1007/s12020-012-9637-8

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  31 in total

Review 1.  Gender differences in Parkinson's disease: clinical characteristics and cognition.

Authors:  Ivy N Miller; Alice Cronin-Golomb
Journal:  Mov Disord       Date:  2010-12-15       Impact factor: 10.338

2.  Effect of estrogen receptor agonists treatment in MPTP mice: evidence of neuroprotection by an ER alpha agonist.

Authors:  Myreille D'Astous; Marc Morissette; Thérèse Di Paolo
Journal:  Neuropharmacology       Date:  2004-12       Impact factor: 5.250

3.  Hypersensitivity of aquaporin 4-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine and astrocytic modulation.

Authors:  Yi Fan; Hui Kong; Xueru Shi; Xiulan Sun; Jianhua Ding; Jie Wu; Gang Hu
Journal:  Neurobiol Aging       Date:  2007-03-13       Impact factor: 4.673

4.  Differential expression of estrogen receptor alpha and beta in rat dorsal root ganglion neurons.

Authors:  N Taleghany; S Sarajari; L L DonCarlos; L Gollapudi; M M Oblinger
Journal:  J Neurosci Res       Date:  1999-09-01       Impact factor: 4.164

5.  Aromatase in developing sensory systems of the rat brain.

Authors:  T L Horvath; K C Wikler
Journal:  J Neuroendocrinol       Date:  1999-02       Impact factor: 3.627

6.  Ablation of estrogen receptor alpha or beta eliminates sex differences in mechanical pain threshold in normal and inflamed mice.

Authors:  Lili Li; Xiaotang Fan; Margaret Warner; Xiao-Jun Xu; Jan-Ake Gustafsson; Zsuzsanna Wiesenfeld-Hallin
Journal:  Pain       Date:  2009-03-13       Impact factor: 6.961

Review 7.  Estrogen and SERM neuroprotection in animal models of Parkinson's disease.

Authors:  Marc Morissette; Sara Al Sweidi; Sophie Callier; Thérèse Di Paolo
Journal:  Mol Cell Endocrinol       Date:  2008-04-22       Impact factor: 4.102

8.  Quantitative measurement of pain sensation in patients with Parkinson disease.

Authors:  R Djaldetti; A Shifrin; Z Rogowski; E Sprecher; E Melamed; D Yarnitsky
Journal:  Neurology       Date:  2004-06-22       Impact factor: 9.910

Review 9.  Neuroprotective actions of sex steroids in Parkinson's disease.

Authors:  Mélanie Bourque; Dean E Dluzen; Thérèse Di Paolo
Journal:  Front Neuroendocrinol       Date:  2009-05-03       Impact factor: 8.606

10.  Broad modulation of neuropathic pain states by a selective estrogen receptor beta agonist.

Authors:  Fabrice Piu; Cindy Cheevers; Lene Hyldtoft; Luis R Gardell; Andria L Del Tredici; Carsten B Andersen; Luke C Fairbairn; Birgitte W Lund; Magnus Gustafsson; Hans H Schiffer; John E Donello; Roger Olsson; Daniel W Gil; Mark R Brann
Journal:  Eur J Pharmacol       Date:  2008-05-23       Impact factor: 4.432

View more
  2 in total

1.  Targeted deletion of GD3 synthase protects against MPTP-induced neurodegeneration.

Authors:  Y Akkhawattanangkul; P Maiti; Y Xue; D Aryal; W C Wetsel; D Hamilton; S C Fowler; M P McDonald
Journal:  Genes Brain Behav       Date:  2017-04-18       Impact factor: 3.449

Review 2.  Neuro-Immunity and Gut Dysbiosis Drive Parkinson's Disease-Induced Pain.

Authors:  Katiane Roversi; Natalia Callai-Silva; Karine Roversi; May Griffith; Christos Boutopoulos; Rui Daniel Prediger; Sébastien Talbot
Journal:  Front Immunol       Date:  2021-11-18       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.